empty

NICE

14 results found for: NICE

Development of UK alcohol clinical guidelines underway

PHE is collaborating with the Scottish, Welsh and Northern Ireland governments to produce the first UK-wide clinical guidelines for alcohol misuse.

Renal therapeutics: part three

Part three of this renal therapeutics CPPE module looks at chronic kidney disease, its causes and how to prevent its progression.

CPPE on... Sepsis

With sepsis awareness a focus of the CPCF, a new gateway page on the topic has been launched by CPPE.

Antimicrobial Resistance

This CPD module looks at antimicrobial resistance and the pharmacy team's role in tackling this patient safety threat.  

European authorities approve cannabis-based medicine for epilepsy

European authorities have for the first time approved a cannabis-based medicine for use in severe childhood epilepsy.

NICE approves cluster headaches device

A handheld device that delivers a small electric current has been recommended in draft guidance by NICE.

New NICE guidelines on hypertension treatment

The new recommendations reduce the CVD risk threshold at which treatment for hypertension should be considered.

NICE chief executive to stand down

Sir Andrew Dillon has announced his intention to stand down as chief executive at the National Institute for Health and Care Excellence (NICE).

‘Not enough evidence’ to recommend cannabis says NICE

NICE has decided not to recommend the use of cannabis-based medicines in severe treatment-resistant epilepsy.

Integrate pharmacists into diabetes care, says RPS

Pharmacists in all settings should be integrated into services aimed at preventing and managing type 2 diabetes.

NICE champions community pharmacy

NICE has published guidance covering how community pharmacies can help maintain and improve people’s physical and mental health and wellbeing, including people with long-term conditions.

NICE update for dementia

People with dementia should be involved in discussions about their care, says NICE in its latest guideline update for the condition.

New NICE guidance for anti-migraine device

NICE states that Cefaly, a device for the treatment and prevention of migraines, can safely be used within the NHS 

NICE urges safer use of controlled drugs

NICE’s guidance will help care professionals “negotiate complex legislation and regulations”, says the body.